Tech Center 3700 • Art Units: 3763 3767 3783
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18457043 | AXIAL SUPPORT STRUCTURE FOR A FLEXIBLE ELONGATE DEVICE | Final Rejection | INTUITIVE SURGICAL OPERATIONS, INC. |
| 17130328 | BIOPSY NEEDLE FOR ACCESSING PERIPHERAL LUNG NODULES | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 17162065 | DOSAGE RECOMMENDATION FACILITATED BY ARTIFICIAL INTELLIGENCE | Final Rejection | Medtronic MiniMed, Inc. |
| 17624030 | Tip Cap for a Medical Injection Device | Final Rejection | Becton Dickinson France |
| 18955026 | CHEMICAL ABLATION FORMULATIONS AND METHODS OF TREATMENTS FOR VARIOUS DISEASES | Non-Final OA | Neurotronic, Inc. |
| 18770797 | DEVICES AND METHODS FOR POSTERIOR EYE SEGMENT ACCESS WITH ACCURATE LOCALIZATION AND NEEDLE PENETRATION DEPTH | Final Rejection | Unity Health Toronto |
| 17625053 | HYBRID SAFETY SPRING CLIP FOR SHARP MEDICAL DEVICES AND RELATED METHODS | Non-Final OA | B. Braun Melsungen AG |
| 17811217 | METHODS AND APPARATUS FOR DELIVERY OF OCULAR IMPLANTS | Non-Final OA | Allergan, Inc. |
| 17530334 | FEEDING TUBE | Final Rejection | GBUK Group Limited |
| 18406777 | Neurovascular Distal Access Support Catheters, Aspiration Catheters, or Device Shafts | Non-Final OA | eLum Technologies, Inc. |
| 18169376 | METHODS AND COMPOSITIONS FOR CONSISTENT INTRACORONARY ADMINISTRATION OF A BIOLOGIC | Final Rejection | Sardocor Corp. |
| 17683421 | METHODS AND APPARATUS FOR EXTRACTING FLUID FROM CONTAINER | Non-Final OA | CLEARSIDE BIOMEDICAL, INC. |
| 17954204 | INFUSION SYSTEM FOR SHORT-LIVED RADIOPHARMACEUTICALS | Final Rejection | MedTrace Pharma A/S |
| 17489633 | SUBARACHNOID FLUID CONDUIT SYSTEM AND KIT | Non-Final OA | EnClear Therapies, Inc. |
| 17749559 | DRUG INJECTION DEVICE | Non-Final OA | Tymphany worldwide Enterprises Limited |
| 17373511 | MEDICAL ACCESS PORTS, TRANSFER DEVICES AND METHODS OF USE THEREOF | Non-Final OA | VERSAGO VASCULAR ACCESS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy